These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11409037)

  • 1. Biophysical analysis of normal transthyretin: implications for fibril formation in senile systemic amyloidosis.
    Chung CM; Connors LH; Benson MD; Walsh MT
    Amyloid; 2001 Jun; 8(2):75-83. PubMed ID: 11409037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils.
    Cardoso I; Goldsbury CS; Müller SA; Olivieri V; Wirtz S; Damas AM; Aebi U; Saraiva MJ
    J Mol Biol; 2002 Apr; 317(5):683-95. PubMed ID: 11955017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation.
    Lashuel HA; Lai Z; Kelly JW
    Biochemistry; 1998 Dec; 37(51):17851-64. PubMed ID: 9922152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transthyretin forms amyloid fibrils at physiological pH with ultrasonication.
    Misumi Y; Ueda M; Fujimori H; Shinriki S; Meng W; Kim J; Saito S; Obayashi K; Uchino M; Ando Y
    Amyloid; 2008 Dec; 15(4):234-9. PubMed ID: 19065294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.
    Lai Z; Colón W; Kelly JW
    Biochemistry; 1996 May; 35(20):6470-82. PubMed ID: 8639594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis.
    Gustavsson A; Jahr H; Tobiassen R; Jacobson DR; Sletten K; Westermark P
    Lab Invest; 1995 Nov; 73(5):703-8. PubMed ID: 7474944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimentally derived structural constraints for amyloid fibrils of wild-type transthyretin.
    Bateman DA; Tycko R; Wickner RB
    Biophys J; 2011 Nov; 101(10):2485-92. PubMed ID: 22098747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The most pathogenic transthyretin variant, L55P, forms amyloid fibrils under acidic conditions and protofilaments under physiological conditions.
    Lashuel HA; Wurth C; Woo L; Kelly JW
    Biochemistry; 1999 Oct; 38(41):13560-73. PubMed ID: 10521263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates.
    Sousa MM; Cardoso I; Fernandes R; Guimarães A; Saraiva MJ
    Am J Pathol; 2001 Dec; 159(6):1993-2000. PubMed ID: 11733349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transthyretin Misfolding, A Fatal Structural Pathogenesis Mechanism.
    Si JB; Kim B; Kim JH
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology.
    Bergström J; Gustavsson A; Hellman U; Sletten K; Murphy CL; Weiss DT; Solomon A; Olofsson BO; Westermark P
    J Pathol; 2005 Jun; 206(2):224-32. PubMed ID: 15810051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid and nonfibrillar deposits in mice transgenic for wild-type human transthyretin: a possible model for senile systemic amyloidosis.
    Teng MH; Yin JY; Vidal R; Ghiso J; Kumar A; Rabenou R; Shah A; Jacobson DR; Tagoe C; Gallo G; Buxbaum J
    Lab Invest; 2001 Mar; 81(3):385-96. PubMed ID: 11310831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro.
    Sousa MM; Fernandes R; Palha JA; Taboada A; Vieira P; Saraiva MJ
    Am J Pathol; 2002 Nov; 161(5):1935-48. PubMed ID: 12414539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clusterin regulates transthyretin amyloidosis.
    Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS
    Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the stabilities of synthetic
    Raimondi S; Mangione PP; Verona G; Canetti D; Nocerino P; Marchese L; Piccarducci R; Mondani V; Faravelli G; Taylor GW; Gillmore JD; Corazza A; Pepys MB; Giorgetti S; Bellotti V
    J Biol Chem; 2020 Aug; 295(33):11379-11387. PubMed ID: 32571879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling transthyretin (TTR) amyloid diseases, from monomer to amyloid fibrils.
    Criddle RS; Hansen LD; Woodfield BF; Tolley HD
    PLoS One; 2024; 19(6):e0304891. PubMed ID: 38843135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin.
    Higaki JN; Chakrabartty A; Galant NJ; Hadley KC; Hammerson B; Nijjar T; Torres R; Tapia JR; Salmans J; Barbour R; Tam SJ; Flanagan K; Zago W; Kinney GG
    Amyloid; 2016 Jun; 23(2):86-97. PubMed ID: 26981744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in pathological and biochemical findings of systemic tissue sites in familial amyloid polyneuropathy more than 10 years after liver transplantation.
    Oshima T; Kawahara S; Ueda M; Kawakami Y; Tanaka R; Okazaki T; Misumi Y; Obayashi K; Yamashita T; Ohya Y; Ihse E; Shinriki S; Tasaki M; Jono H; Asonuma K; Inomata Y; Westermark P; Ando Y
    J Neurol Neurosurg Psychiatry; 2014 Jul; 85(7):740-6. PubMed ID: 24023270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological, biochemical, and biophysical characteristics of the transthyretin variant Y114H (p.Y134H) explain its very mild clinical phenotype.
    Sekijima Y; Campos RI; Hammarström P; Nilsson KP; Yoshinaga T; Nagamatsu K; Yazaki M; Kametani F; Ikeda S
    J Peripher Nerv Syst; 2015 Dec; 20(4):372-9. PubMed ID: 26306725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and characterization of aggregates, prefibrillar amyloidogenic oligomers, and protofibrils using fluorescence spectroscopy.
    Lindgren M; Sörgjerd K; Hammarström P
    Biophys J; 2005 Jun; 88(6):4200-12. PubMed ID: 15764666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.